I-Mab (NASDAQ:IMAB)’s traded shares stood at 0.89 million during the last session. At the close of trading, the stock’s price was $71.01, to imply a decrease of -2.97% or -$2.17 in intraday trading. The IMAB share’s 52-week high remains $85.40, putting it -20.26% down since that peak but still an impressive 54.03% since price per share fell to its 52-week low of $32.64. The company has a valuation of $5.16B, with an average of 0.48 million shares in intraday trading volume over the past 10 days and average of 654.74K shares over the past 3 months.
Analysts have given a consensus recommendation of a Buy for I-Mab (IMAB), translating to a mean rating of 1.70. Of 12 analyst(s) looking at the stock, 0 analyst(s) give IMAB a Sell rating. 1 of those analysts rate the stock as Overweight while 0 advise Hold as 11 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.
I-Mab (NASDAQ:IMAB) trade information
After registering a -2.97% downside in the last session, I-Mab (IMAB) has traded red over the past five days. The stock hit a weekly high of 76.81 this Friday, 10/08/21, dropping -2.97% in its intraday price action. The 5-day price performance for the stock is -1.00%, and -8.10% over 30 days. With these gigs, the year-to-date price performance is 50.60%. Short interest in I-Mab (NASDAQ:IMAB) saw shorts transact 1.78 million shares and set a 3.89 days time to cover.
Analysts on Wall Street suggest a consensus price target of $95.09, implying an increase of 25.32% to the stock’s current value. The extremes give us $83.00 and $102.98 for target low and target high price respectively. As such, IMAB has been trading -45.02% off suggested target high and -16.88% from its likely low.
I-Mab (IMAB) estimates and forecasts
Looking at statistics comparing I-Mab share performance against respective industry, we note that the company has underperformed competitors. I-Mab (IMAB) shares are 48.37% up over the last 6 months, with its year-to-date growth rate lower than industry average at -227.35% against 7.00%.
I-Mab has its next earnings report out on March 29. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. I-Mab has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
I-Mab (NASDAQ:IMAB)’s Major holders
I-Mab insiders hold 0.84% of total outstanding shares, with institutional holders owning 38.62% of the shares at 38.95% float percentage. In total, 38.62% institutions holds shares in the company, led by Hillhouse Capital Advisors Ltd. As of Mar 30, 2021, the company held over 6.62 million shares (or 8.60% of shares), all amounting to roughly $320.69 million.
The next major institution holding the largest number of shares is Cederberg Capital Ltd with 2.13 million shares, or about 2.77% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $103.18 million.
We also have Artisan International Small-Mid Fund and Price (T.Rowe) New Asia Fund as the top two Mutual Funds with the largest holdings of the I-Mab (IMAB) shares. Going by data provided on Mar 30, 2021, Artisan International Small-Mid Fund holds roughly 0.6 million shares. This is just over 0.78% of the total shares, with a market valuation of $29.0 million. Data from the same date shows that the other fund manager holds a little less at 0.54 million, or 0.71% of the shares, all valued at about 33.24 million.